Trial Profile
A Randomized, Open-label, Cross-over Study to Evaluate Patient Preferences for Eucreas Versus Victoza as add-on to Metformin in Type 2 Diabetes Mellitus Patients Who Did Not Have Adequate Glycaemic Control With Metformin.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Vildagliptin/metformin (Primary) ; Liraglutide; Metformin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms PREFER
- 20 Mar 2012 New source identified and integrated (European Clinical Trials Database, EudraCT2011-003818-16).
- 01 Feb 2012 New trial record